Harvey Brian Nicholas 4
4 · Adicet Bio, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Harvey Brian Nicholas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-24+288,022→ 288,022 totalExercise: $2.40Exp: 2034-01-23→ Common Stock (288,022 underlying) - Tax Payment
Common Stock
2024-01-24$2.40/sh−4,320$10,368→ 73,500 total - Award
Common Stock
2024-01-24+26,300→ 99,800 total
Footnotes (3)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
- [F2]The Reporting Person was issued RSUs. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in three (3) annual installments, with the first tranche vesting on January 24, 2025. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
- [F3]1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.